The University of Chicago Header Logo

Connection

Seiko Diane Yamada to Sirolimus

Back to Details
This is a "connection" page, showing publications Seiko Diane Yamada has written about Sirolimus.
Seiko Diane Yamada
Connection Strength
0.101
Sirolimus
  1. Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr; 129(1):22-7.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.